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Alcohol abuse is an enormous problem causing death and disability to over 43 
million people worldwide each year (WHO).  Chronic alcohol consumption also 
contributes to abnormal brain morphology and significant brain volume loss indicative of 
neurodegeneration.  Until there are effective treatments to alter maladaptive behavioral 
patterns in alcohol abuse, more research is needed to prevent alcohol-induced toxicity 
and degeneration.  We used C. elegans as a model system to identify genetic modulators 
of alcohol toxicity and explored whether prolonged alcohol exposure damages the 
nervous system.  In our study, we exposed L4-larval stage worms to varying 
concentrations of ethanol for three days and found a dose-dependent deficit in crawling.  
Furthermore, we evaluated degeneration by assessing the health of neurons using 
fluorescent reporters.  Compared to the untreated group, we found that ethanol-exposed 
worms had a significant neurodegeneration.  Previous findings using C. elegans have 
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suggested that the innate immune pathway may protect against neurodegeneration caused 
by drug toxicity (Schreiber & McIntire, 2012). We find that deletion of either the innate 
immune gene nsy-1 (orthologous to the mammalian ASK-1 MAPKKK) or pmk-1 
(orthologous to the mammalian p38 MAPK) caused hypersensitivity to ethanol toxicity.  
Conversely, boosting innate immune signaling via gain-of-function mutation in nsy-1 
produced resistance to ethanol toxicity and ameliorated ethanol-induced cholinergic 
degeneration.  Our findings indicate that prolonged exposure to ethanol leads to both 
behavioral impairments and neuronal degeneration in C. elegans and that the ASK1/p38 
MAP kinase pathway may play a role in ethanol-induced damage to the nervous system.  
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Chapter One: Review on alcohol-induced neurodegeneration and innate 
immunity 
INTRODUCTION 
Innate immune system function is the first line of defense against all types of 
exogenous pathogens, toxins and injury. Upon infection, the innate immune system 
activates signaling cascades that ultimately induce inflammation, immunity and repair. 
The innate immune system and its role in disease have received significant attention over 
the past decades.  Increasing evidence in animal models indicates that sustained 
inflammation due to a dysregulated innate immune system results in tissue pathology and 
production of neurotoxic agents— components that are directly linked to 
neurodegenerative diseases. Understanding mechanisms of innate immune system 
activation as it produces inflammatory responses will be vital for providing therapeutic 
strategies for the prevention and treatment of chronic degenerative diseases.  
Due to its well-established role in the pathogenesis of many CNS disorders, 
understanding the innate immune system inflammatory response as it relates to 
alcoholism and alcohol-induced brain damage has been an expanding area of interest. 
Recent discoveries have provided evidence of a direct link between alcohol-induced brain 
damage and immune system activation, specifically, neuroinflammation. Alcohol 
exposure results in Toll-like receptors (TLRs) activation, phosphorylation of mitogen-
activated protein (MAP) kinase pathways and proinflammatory cytokine production. 
These exciting discoveries have elucidated mechanisms by which chronic alcohol 
consumption induces both short and long term damage to the central nervous system. 
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Advances within the areas of neuroimmunology and alcohol abuse may provide new 
approaches for the treatment of alcohol-induced neurodegeneration and brain damage.  
INNATE IMMUNE SIGNALING PATHWAY 
Increasing evidence within the ethanol and neuroimmunology field has suggested 
a critical role for Toll-like receptors (TLRs) in alcohol-induced brain damage. TLRs are a 
family of highly conserved membrane glycoproteins that recognize molecules, or 
pathogen-associated molecular patterns (PAMPs), derived from microbes. TLRs were 
first cloned in Drosophila, and so far, 11 mammalian homologs have been characterized 
(Hashimoto et al., 1988). TLRs form a complex with the superfamily of proteins known 
as interleukin-1 receptors (IL-1R). This complex is activated upon binding of different 
ligands including bacterial lipopolysaccharide (LPS), heat shock proteins and 
lipopeptides. Some of the molecules needed to initiate the immune signaling cascade 
include myeloid differentiation primary-response protein 88 (MyD88), IL-1R-associated 
kinase (IRAK), transforming growth factor-β (TGF-β)-activated kinase (TAK1), TAK1-
binding protein 1 (TAB1), TAB2 and tumour-necrosis factor (TNF)-receptor-associated 
factor 6 (TRAF6) (See figure 1). Collectively, recruitment of these downstream signaling 
molecules can activate mitogen-activated protein kinase (MAPK) pathways. Stimulation 
of the MAPK signaling cassette results in activation of transcription factors (TFs) — AP-
1 and NF-κB. Ultimately, stimulation of AP-1 and Nf-κB increases expression of genes 
that encode pro-inflammatory mediators such as inflammatory cytokines (Li et al., 2002; 
Akira and Takeda, 2004, Nguyen et al., 2002).  
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MAMMALIAN MAP KINASE (MAPK) SIGNAL TRANSDUCTION PATHWAYS 
Mammalian MAPKs can also be activated by endogenous stimuli such as growth 
factors, hormones and cytokines as well as environmental factors including UV 
irradiation, heat shock and injury. Currently, there are six different groups of MAPKs that 
have been characterized—extracellular regulated kinases (ERK) 1/2, ERK 7/8, ERK 3/4, 
ERK5, Jun terminal kinases (JNK 1/2/3) and lastly, p38 (p38 α/β/ϒ/δ). MAPK signaling 
induces downstream phosphorylation of MAPK kinase kinase (MAP3Ks), MAPK kinase 
(MAPKK) and MAPK, which act via downstream substrates (i.e. CREB, AP-1, etc.) and 
eventually induce expression of MAPK-activated protein kinases (MKs). Activation of 
these pathways has been implicated in many different biological responses and processes 
including cell proliferation, survival, apoptosis and inflammation (Krishna and Narang, 
2008).  
The p38 MAPK pathway has been extensively studied, and its critical role in 
innate immune response has received significant attention over the past decades.  Some 
of the upstream activators of p38 kinases are MKK3, MKK6, ASK1 and TAK1; upon 
activation, p38 phosphorylates downstream targets that include transcription factors (TF)  
(i.e. ATF and CREB), which lead to activation of genes that encode proinflammatory 
proteins. Studies have indicated that activation of p38 initiates production of pro-
inflammatory cytokines, enzymes such as cyclooxygenase-2 (COX-2) and inducible 
nitric oxide synthase (iNOS) (Pietersma et al, 1997; Krishna and Narang, 2008).  
Additionally, activation of the p38 MAPK pathway regulates expression of 
proinflammatory genes via post-transcriptional and post-translational mechanisms 
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(Bolling et al., 2003). Although the role of p38 MAPK has been found to be essential in 
immune function, the exact mechanisms involved in p38 functions remain elusive. 
Moreover, due to its involvement in various cellular processes (i.e. cell cycle, apoptosis, 
cell survival, differentiation and development, etc.)  its categorization to a specific 
response has been proven difficult. 
INNATE IMMUNITY IN C. ELEGANS 
 Although the mammalian immune system consists of innate and adaptive layers 
of protection, the nematode worm C. elegans relies solely on innate immune system 
activation against pathogenic attack. This is one of the advantages of using C. elegans as 
a model organism for the study of innate immunity—it allows for a clear dissection and 
characterization of key innate immunity components independent from adaptive immune 
system interaction.  Similarly, C. elegans is a powerful tool that provides a genetically 
tractable model system that can be used to identify genes responsible for innate immune 
response at the molecular and cellular levels. One approach that has been fundamental in 
the identification of innate immune genes is through the use of genetic screens.  Here, 
worms are exposed to a strong mutagen, which results in random gene mutations in the 
subsequent generation of worms.  Genetic manipulations available in C. elegans offer 
complementary tools for studying the contribution of individual genes to innate immune 
function.  
Although the innate immune system is conserved across species, there are certain 
differences between C. elegans and mammalian immune systems. Firstly, there are no 
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known homologs of the transcription factor NF-κB or adaptor protein MYD88. Secondly, 
the C. elegans gene tol-1, orthologous to the mammalian Tlr genes, does not appear to 
regulate innate immune response upon PAMP exposure. Thirdly, there are no known 
cytokines produced by the C. elegans innate immune system upon microbe infection.  
Although some of important components of mammalian innate immune system are not 
encoded in the C. elegans genome, there are, however, evolutionarily conserved signal 
transduction pathways including p38 MAPK, β-catenin, and FOXO, which are activated 
during immune response (Troemel et al., 2006; Pukkila-Worley et al., 2012) Furthermore, 
due to the lack of homology to NF-kB and MYD88 mediated immune response, C. 
elegans is a powerful genetic model, which has proven useful in identifying and 
elucidating TLR-independent components of innate immunity.  
RECENT STUDIES IN C. ELEGANS INNATE IMMUNITY 
 Genetic screens have yielded important discoveries in innate immunity C. 
elegans.  For instance, the mammalian p38 mitogen-activated protein (MAP) kinase 
pathway has been identified to be homologous with the C. elegans NSY-1/SEK-1/PMK-1 
pathway. NSY-1 is orthologous to the mammalian ASK-1 gene; SEK-1 mammalian 
ortholog is MKK3/MKK6 and PMK-1 is orthologous to the mammalian p38 MAP 
kinase. Activation of nsy-1 requires activation of the upstream gene tir-1, orthologous to 
the mammalian SARM. Additionally, recent findings have indicated that the nsy-1/sek-
1/pmk-1 pathway is activated upon exposure to pathogen infection, osmotic stress and 
biogenic amines (Hisamoto et al., 2001; Kim et al., 2002; Schreiber and Mcintire, 2012). 
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  nsy-1, sek-1, pmk-1 null mutants exhibited higher susceptibility to killing by a 
wide variety of infections including Gram-negative pathogens P. aeruginosa (Kim et al., 
2002; Troemel et al., 2006), Salmonella enterica (Aballay et al., 2003), Yersinia pestis 
(Bolz et al., 2010) and Serratia marcescens (Shivers et al., 2010); as well as the Gram-
positive pathogens Enterococcus faecalis (Shivers et al., 2010) and Staphylococcus 
aureus (Sifri et al., 2003). Similarly, it was discovered that sek-1 and pmk-1 are required 
for defense against oxidative agents as well as the crystal toxin produced by Bacillus 
thuringensis, respectively (Inoue et al. 2005;Troemel et al., 2006;). Together, these 
findings have provided important insight into conserved aspects of innate immune 
pathways. Combining findings in C. elegans and rodent models will shed light to the 
molecular components of innate immune response and their involvement in human 
disease.   
LPS: ITS ROLE IN NEURODEGENERATION AND ALCOHOLISM 
Lipopolysaccharide (LPS) is an endotoxin present in the outer membranes of 
Gram-negative bacteria. LPS binding to TLRs activates a signaling cascade, which 
ultimately results in an immune response. Studies have demonstrated that systemic or 
central administration of LPS induces the expression of proinflammatory cytokine 
mRNAs and proteins such as IL-1β AND TNF- α in the brain (Van Dam et al., 1992; 
Laye et al., 1994; Quan et al., 1999).  Although LPS is one of several other molecules 
recognized by TLRs— the interaction between LPS and TLRs and their role in 
neuroinflammation/neurodegeneration remain elusive.  
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Recent studies demonstrated that shortly after systemic LPS and alcohol 
administration induced increases in TNF-α production (Qin et al., 2008). This was one of 
the first studies to suggest a link between systemic LPS and cytokine-mediated 
neuroinflammation. Shortly after this discovery, Qin and colleagues extended their 
previous study by administering 3 mg/kg of LPS and measuring its immediate (1hr post 
LPS administration) and chronic (10 days ethanol treatment) effect on cytokine 
production. They found that LPS quickly generated significant increases in TNFα, MCP-
1, and IL-1β mRNA and protein levels in mouse brain, serum and liver.  
A recent study by Blednov and colleagues (2011) described the effect of LPS 
administration on alcohol consumption. Different strains of mice were tested for alcohol 
preference, motivation and consumption following LPS administration. They found that 
two injections of LPS produced persistent increases in alcohol consumption, and that this 
effect was dependent on genetic background and gender (Blednov et al., 2011). Their 
results are consistent with previous findings-- mice lacking functional chemokines, 
cytokines, or TLR4 show reduced ethanol consumption in comparison to wild type. The 
results of this study strongly suggest that there is a neuroimmune regulation of ethanol 
consumption and that innate immune signaling may indirectly promote alcohol drinking 
in mice and possibly humans.  
TLR4 IS ACTIVATED BY ETHANOL 
It was recently discovered that acute or chronic ethanol exposure activated glial 
cells by stimulating the TLR4 and IL-1R signal transduction pathways in cultured 
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astrocytes (Blanco et al., 2005). Subsequent studies by Silvia Alfonso-Loeches et al. 
demonstrated that TLR4 is essential for ethanol-induced neuroinflammatory signaling 
since TLR4-deficient mice did not show activation of astrocytes, pro-inflammatory 
cytokines as well as MAPK and NFkB signaling pathways after chronic ethanol exposure 
(Alfonso-Loeches et al., 2010). This was the first study to provide evidence that glia 
activation following ethanol exposure is associated with increased levels of pro-
inflammatory molecules IL-1, caspase-3, iNOS and COX-2 in wild type mice.  
Further corroborating the role of TLR4 signaling in ethanol-induced effects, a 
study by Wu and colleagues (2012) found that inhibiting the TLR4/MyD88 signaling 
cascade using either naloxone (an opioid and TLR4 antagonist) or TLR4 or MyD88- 
knockout mice reduced sedation and motor impairment in mice that were acutely exposed 
to ethanol. In this particular study, naïve mice with null mutations in the Tlr4 and Myd88 
genes were injected with a single, high or moderate, alcohol dose and were assessed for 
alcohol-induced sedation and motor dysfunction. Furthermore, Tlr4 and Myd88 knockout 
mice were assessed for alcohol-induced behavioral changes following naloxone treatment 
before alcohol exposure. They found that mice null in Tlr4 and Myd88 recover more 
quickly from alcohol-induced motor impairment and sedation. They also found that low 
and high alcohol doses activate proinflammatory-signaling molecules within the CNS. 
However, they did not observe p38, JNK or ERK phosphorylation following acute 
ethanol exposure in hippocampal cells in vitro. Their data contradict previous findings by 
Alfonso-Loeches et al., indicating that the mechanisms underlying chronic and acute 
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ethanol-induced neuroinflammation may be constitutively different. Their data suggest 
that other inflammatory mediators may also be involved in the alcohol-induced 
inflammatory damage in the brain.   
Although the mechanism by which ethanol interacts and promotes TLR4 and IL-
1R recruitment remains unknown, a study by Blanco et al., found that stimulation and 
signaling of TLR4/IL-1R complex in glia occurs exclusively through lipid rafts, or 
cholesterol-enriched plasma membrane microdomains. Additionally, they suggest that 
ethanol is a TLR4 and IL-1R agonist and that it may interact with other proinflammatory 
signaling molecules including IRAK and ERK (Blanco et al., 2008).   
NF-ΚB AND ITS ROLE IN NEURODEGENERATION AND ALCOHOLISM 
NF-κB is a family of transcription factors (TFs) known for their regulation of 
genes involved in immune response, synaptic plasticity, cell death/cell survival, and 
inflammation (Crews et al., 2006; Rulten et al., 2006; Ward et al., 1996; Zou and Crews, 
2006, 2010). In its inactive form, the NF-κB family of dimers is composed of five 
members: p65, p50, REL-B, cytoplasmic REL, and p52.   NF-κB heterodimer (p65/p50) 
is kept inactive by IκB—an inhibitor protein that keeps NF-κB from translocating to the 
nucleus (Akira and Takeda, 2004).  NF-κB can be activated by a variety of extracellular 
stimuli such as growth factors, inflammatory mediators and glutamatergic excitotoxicity.  
(Yakovleva et al., 2011). Additionally, it was recently demonstrated that chronic or acute 
ethanol exposure activates NF-κB TFs in the CNS resulting in downstream activation of 
TNF-α and proinflammatory cytokines (Crews et al., 2006). A different study performed 
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DNA microarray analysis in ethanol treated mice in order to identify ethanol-regulated 
genes. Upon either acute or chronic ethanol administration, they found that ethanol 
differentially regulated the NF-κB pathway in a dose-dependent manner: acute ethanol 
treatment resulted in increased NF-κB protein expression, whereas chronic ethanol 
treatment led to significant inhibition of NF-κB transcription (Rulten et al., 2006). These 
findings provide evidence that at the mammalian transcripitional level, ethanol may be 
acting via the NF-κB pathway.  
CYTOKINES AND ETHANOL 
It was recently discovered that there is reciprocal communication between the 
brain and the immune system, mediated by signaling molecules known as cytokines. 
Cytokines are widely expressed in glia (astrocytes and microglia) and their receptors are 
ubiquitously expressed in all cell types in the CNS. During physiological conditions, 
cytokines regulate inflammation by producing pro or anti-inflammatory responses. For 
instance, pro-inflammatory cytokines such as tumor-necrosis factor-α (TNF-α), 
interleukin-1 (IL-1) and IL-6 levels are elevated during brain injury as well as in response 
to infections and endotoxins. Increased cytokine production has been associated with a 
variety of pathologies such as neurodegenerative diseases including Alzheimer’s disease, 
Parkinson’s disease, amyotrophic lateral sclerosis and multiple sclerosis, mood disorders 
(depression) as well as alcoholism (Glass et al., 2010).  
The effect of alcohol on cytokine production and innate immune activation is 
complex and variable. For instance, during the last decade, it has been established that 
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alcohol consumption causes increased levels in both systemic and brain levels of 
cytokines.  Specifically, chronic alcohol intake in humans was associated with elevated 
levels of TNF- α, IL-1 and IL-6 (McClain et al., 2004; McClain and Cohen, 1989 and 
Crews et al., 2006). Conversely, low to moderate alcohol consumption has been shown to 
reduce the risk of developing type-2 diabetes and coronary heart disease (Hendriks and 
Van Tol, 2005; Collins et al., 2009, Sinforiani et al., 2011). It is proposed that the 
mechanism by which alcohol protects from these diseases is by inducing anti-
inflammatory signals via anti-inflammatory cytokines such as IL-4 and IL-10.  In vitro 
studies demonstrated that moderate alcohol exposure increased production of IL-10 in 
monocytes. Additionally, they found that alcohol treatment in macrophages inhibited the 
production of proinflammatory cytokines via the NF-kB pathway (Mandrekar et al., 
2001).  Both of these findings suggest that light-to-moderate alcohol intake exerts anti-
inflammatory effects by both suppressing pro-inflammatory signals as well as by 
increasing anti-inflammatory cytokine production. Collectively, this evidence suggests 
that ethanol induces different effects on cytokine production and immune response 
depending on the dosage (acute or chronic exposure) and on the history of alcohol 
consumption (see figure 2).  
INCREASED MCP-1 IN THE ALCOHOLIC BRAIN   
 Another important cytokine that has been implicated in alcohol-induced 
neuroinflammation and ethanol consumption is monocyte chemoattractant protein-1 
(MCP-1 or also known as CCL2) (Blednov et al., 2005). For instance, a study in human 
postmortem brains of alcoholics found elevated MCP-1 protein concentration in the 
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ventral tegmental area (VTA), substantia nigra, hippocampus and amygdala in 
comparison to non-alcoholic brains (He et al., 2008). This evidence identifies another key 
component in the neuroimmune involvement in alcohol-induced brain damage. 
ALCOHOL-INDUCED CNS DAMAGE 
Chronic alcohol exposure results in a dysregulation of the innate immune system 
by altering cytokine expression and immune response, all which may ultimately lead to 
long-term damage to the central nervous system. For example, individuals who consumed 
alcohol chronically had abnormal brain morphology, significant volume loss and reduced 
neurogenesis (Crews and Nixon, 2009), all of which are indicative of neurodegeneration.  
It has been noted that alcohol-induced neurodegeneration occurs during intoxication, and 
that the frequency and recency of binge-drinking episodes best predicts the extent of 
alcohol-induced brain damage.  
Severe alcohol abuse impairs learning and memory abilities and can sometimes 
develop into more severe forms of mental dysfunction such as alcoholic-related amnesia 
and/or dementia.  The most common form of alcoholic amnesia is Korsakoff’s syndrome, 
being the second leading cause of adult dementia in the U.S. (Eckard and Martin, 1986) -- 
characterized by severe memory loss, impaired executive function and apathy (Kessels 
and Kopelman, 2012). Although memory deficits are accompanied by this condition, 
intelligence and other cognitive functions remain intact. Imaging studies have found 
significant changes in morphology and physiology in the brains of alcoholics. These 
changes have been associated with the memory loss and cognitive impairments seen in 
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individuals with Korsakoff’s syndrome and alcoholic-related dementia.  Typically, there 
is significant volume loss and weight reduction in the brains of alcoholics (Crews and 
Nixon, 2009).  Specifically, postmortem studies have shown shrinkage of both gray and 
white matter across different brain regions as well as reduced ventricle size (Sullivan and 
Pfefferbaum, 2005). Even though alcohol-induced damage has been observed throughout 
the entire brain, the frontal cortex appears to be particularly vulnerable (Kubota et al., 
2001). Disrupted frontal lobe function contributes to impaired judgment, reduced affect, 
decreased motivation, distractibility, and impulsivity (Crews and Nixon, 2009); behaviors 
that are typically observed in alcoholics.  Other affected brain regions include the 
hypothalamus, medial septal nucleus, insula, cerebellum and hippocampal area (Fadda 
and Rossetti, 1998).  
  In addition to inducing abnormal brain morphology and volume reduction, 
chronic alcohol consumption also inhibits neurogenesis. For instance, a study by Herrera 
et al., (2003) found that ethanol selectively reduced the number of newly formed neurons 
in the dentate gyrus of ethanol dependent animals. A different study found that chronic, 
but not acute, ethanol administration resulted in significantly decreased neurogenesis in 
the dentate gyrus of animals that were pretreated with both ethanol and LPS (Qin and 
Crews, 2008). This, and other studies have found that chronic alcohol exposure results in 
reduced neurogenesis, and that this effect occurs via LPS induced neuroinflammation—
elucidating the mechanism by which chronic alcohol consumption contributes to 
neurodegeneration via an innate immune response.  
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MECHANISM UNDERLYING ALCOHOL-INDUCED CNS DAMAGE 
Currently, the mechanism of alcohol-induced neurodegeneration and how the 
innate immune system is influencing this damage remains unclear. In a binge ethanol 
model of alcohol dependence (Zou and Crews, 2006), it was demonstrated that alcohol 
induced oxidative stress and proinflammatory signals all of which are indicative of 
neurotoxicity and neuronal death. Similarly, ethanol reduced BDNF and CREB-regulated 
gene expression at similar times when neurodegeneration was most noted. Another study 
suggested oxidative damage to have an important role in alcohol-induced neuronal 
damage.  
It has been proposed that NADPH oxidase (NOX) plays in role in alcohol-induced 
neurodegeneration and neurotoxicity. Activation of NOX in microglia results in the 
formation of reactive oxygen species (ROS) in the brain ultimately leading to 
neurotoxicity (Qin et al., 2004). Previous studies found significant increases in 
proinflammatory cytokine, chemokine and ROS levels following chronic alcohol 
exposure. Qin and Crews expanded these findings by establishing a critical role of the 
NOX-ROS complex in alcohol-induced neurodegeneration. Data from this study 
suggested that chronic ethanol consumption leads to long lasting increases in both NOX 
production and proinflammatory oxidative stress in the brains of mice and humans. 
Conversely, treatment with diphenyliodonium (DPI), a known NOX inhibitor, resulted in 
decreased ROS production, which in turn stopped alcohol-induced neurodegeneration in 
ethanol treated mice.  Results from this study further support the theory of 
neuroinflammation and oxidative stress as key mediators in alcohol-induced 
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neurodegeneration and neuronal death (Qin and Crews, 2012). Although this evidence 
elucidates a pathway by which atrophy and degeneration occur following chronic alcohol 
consumption, the exact mechanism that underlie CNS degeneration as a result of chronic 
alcohol consumption remain elusive.  
PROTECTIVE ROLES OF THE INNATE IMMUNE SYSTEM 
 
There have been discrepancies in deciphering the role of inflammatory response 
in neurodegenerative diseases, mood disorders and alcoholism. While an inflammatory 
response due to injury or infection is necessary for repair and protection of neurons as 
well as the maintenance of normal functioning, sustained inflammation can cause 
degeneration and damage to the CNS. Although a growing number of studies have 
demonstrated that proinflammatory molecules have detrimental effects in the CNS, there 
is evidence of beneficial roles of the innate immune response.  
For instance, in a study by Arnett et al. (2001), mice lacking TNF- α and TNF- α 
receptors had a significant reduction in neuronal remyelination in their model of Multiple 
Sclerosis (MS).  They found that TNF receptor 2 (TNFR2), and not TNFR1 was critical 
for oligodendrocyte regeneration, and that TNF- α is involved in nerve remyelination and 
reparation (Arnett et. al 2001). In addition to its involvement in degenerative processes, 
TNF- α has been shown to play a role in ischemic injury as well as epileptic seizures. 
Heldmann et al., (2005) investigated the effect of TNF- α inhibition on the survival of 
hippocampal neurons in rats that had endured an ischemic injury. They found that rats 
treated with anti-TNF antibodies had reduced hippocampal and striatal neurogenesis in 
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comparison to animals given control protein. Theses results suggest that TNF- α 
signaling may be necessary for neuronal repair and survival after an ischemic insult 
(Heldmann et al., 2005).  In a different study by Bruce and colleagues (1996), mice 
genetically deficient in TNF receptors that received an ischemic or excitotoxic brain 
injury exhibited increased neurodegeneration and oxidative stress, indicating that TNF 
may have neuroprotective properties by activating antioxidant pathways (Bruce et al., 
1996).  
Another proinflammatory cytokine that has been linked to CNS repair is 
interleukin-1β (IL-1 β). Its role in the remyelination process was demonstrated in a study 
by Mason et al., (2001). Following curprizone (a strong demyelinating agent that results 
in impairment and death of oligodendrocytes) treatment, IL-1β knockout mice showed 
decreased remyelination as well as insulin-like growth factor-1 (IGF-1) levels in 
comparison to wild-type animals. Together, these findings indicate that receptors and 
cytokines that are involved in the innate immune response (such as TNF and IL-1 β) have 
neuroprotective properties against injury and toxin-induced demyelination. More research 
is needed to elucidate innate immune response and its role in normal brain functions as 
well as in neurodegeneration; currently this mechanism remains unknown, and it appears 
that the immune system can have dual roles in the CNS. 
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Excessive alcohol consumption results in damage to various organs particularly 
the brain. Neuropathologies consequent to chronic alcohol consumption include reduced 
brain volume, abnormal brain morphology and decreased neurogenesis (Crews and 
Nixon, 2009; Fadda and Rossetti, 1998). Conversely, lower to moderate alcohol 
consumption can exert protective actions by reducing the risk of developing type 2 
diabetes, cerebrovascular and coronary heart disease by promoting anti inflammatory and 
anti oxidative processes (Hendriks and Van Tol, 2005; Collins et al., 2009, Sinforiani et 
al., 2009). These findings suggest that alcohol consumption has beneficial and deleterious 
health effects dependent on frequency and dosage of drinking. 
 Emerging evidence indicates a role for innate immune system activation in 
neurodegenerative diseases as well as alcohol abuse disorders. For instance, chronic 
alcohol exposure caused increases in brain levels of inflammatory mediators, 
upregulation of innate immune gene expression and activation of innate immune 
signaling pathways, all which have been implicated in CNS atrophy and degeneration 
(Alfonso-Loeches et al. 2010; Blanco et al., 2005; Arlinde et al., 2004; Zou and Crews, 
2010).  
Despite increasing evidence supporting a role for innate immunity in alcohol-
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induced brain damage, the mechanisms of alcohol-induced neurodegeneration and how 
the innate immune system is influencing this damage remain unclear. We used the 
genetically tractable organism Caenorhabditis elegans to explore molecular and cellular 
mechanisms of alcohol-induced neurodegeneration. Firstly, its short-life span, transparent 
body and well-characterized nervous system allow for a simpler approach to studying 
neurodegeneration.  Secondly, its lack of an adaptive immune system facilitates the study 
of innate immunity independent of adaptive immune system activation.  Lastly, it has 
been demonstrated that C. elegans exhibits behavioral intoxication at physiologically 
relevant ethanol doses, and that these effects are mediated by conserved genes and targets 
in the nervous systems of invertebrates and mammals (Morgan and Sedensky, 1995; 
Bettinger and McIntire, 2004; Davies et al., 2003, 2004; Davis et al., 2008; Graham et al., 
2009; Kapfhamer et al., 2008; Lee et al., 2009; Mitchell et al., 2007; Speca et al., 2010). 
In this study, we developed an in vivo model of chronic alcohol exposure to 
investigate whether high doses of ethanol could result in neuronal degeneration and 
toxicity in C. elegans. Because a novel model of Alzheimer’s disease (AD) developed by 
Crisp et al. (in submission, 2013) demonstrated that a specific subset of neurons (VC-
class cholinergic neurons 4 and 5) were particularly susceptible to amyloid precursor 
protein (APP)-induced degeneration, we explored whether prolonged alcohol exposure 
could also lead to cholinergic neurodegeneration. We discovered that alcohol-treated WT 
worms exhibited notable deficits in crawling as well as increased cholinergic 
degeneration. Additionally, we found that mutations in the nsy-1 gene bidirectionally 
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influenced locomotion rates following chronic alcohol exposure and that boosting activity 
of nsy-1 resulted in enhanced resistance from alcohol-induced neurodegeneration and 
toxicity. 
RESULTS 
There is a dose-dependent deficit in crawling after prolonged exposure to ethanol 
We first examined the behavioral effects of ethanol in C. elegans. To determine 
appropriate ethanol doses to study chronic (72 hours) ethanol exposure, we treated L4-
larval stage worms with 100mM, 200mM and 400mM ethanol.  Previous work by Davies 
et al. 2003, showed that internal concentrations of ethanol for worms exposed to 400 mM 
and 500 mM ethanol were about 22 mM and 29 mM, respectively. These concentrations 
are equivalent to human blood alcohol concentrations of 0.1% (Davies et al., 2003). 
 We examined crawling behavior by quantifying the number of head bends over a 
20 second period following chronic ethanol exposure.  We found that treatment with 
200mM and 400mM ethanol strongly inhibited crawling behavior as indicated in figure 3 
(p-value = 0.00 for 200mM and 400mM ethanol at α = 0.05). Our results are consistent 
with previous reports that showed dose-dependent depression in locomotion in animals 
treated with ethanol (Davies et al., 2003, 2004; Alaimo et al., 2012; Morgan and 
Sedensky, 1995).  
nsy-1 activity bidirectionally influences ethanol-induced toxicity 
Once we confirmed alcohol-induced behavioral defects using our in vivo assay of 
chronic ethanol exposure and found that 400mM ethanol produced the most dramatic 
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effect on crawling behavior in ‘wild type’ worms, we next examined ethanol-induced 
crawling impairments in animals carrying mutations in the nsy-1 gene (orthologous to the 
mammalian apoptosis signal-regulating kinase 1 (ASK1)). Our rationale for testing these 
strains arose from a study by Schreiber and McIntire, 2012, in which a screen using 
dopamine-induced lethality identified a mutation in the nsy-1 gene that resulted in strong 
resistance to toxic effects of exogenous dopamine as well as various types of 
amphetamines. Furthermore, nsy-1 gene both prevented degeneration and maintained 
neuronal function in a subset of cholinergic and dopaminergic neurons in Alzheimer’s 
disease (AD) and Parkinson’s disease models, respectively. (Schreiber & McIntire, 2012; 
Crisp et al., in submission). 
We hypothesized a protective role for innate immunity; specifically, that boosting 
innate immune signaling, through gain-of-function mutation in nsy-1 enhances resistance 
to ethanol-induced toxicity and neurodegeneration. We found that nsy-1(gf) mutants had 
significantly higher number of head bends (3.8 head bends/20 sec) compared to wild type 
animals (2.2. head bends/20 sec) after chronic ethanol treatment (p-value = 0.00) (Figure 
4). This suggests that increasing nsy-1 activity may be protective of crawling deficits 
associated with ethanol intoxication.  
We next explored whether nsy-1(lf)  mutants showed opposite phenotypes to nsy-
1(gf) strain. We found that nsy-1(lf) worms were hypersensitive to ethanol by showing 
significantly reduced number of head bends in comparison to control ‘wild type’ (p-value 
= 0.005) and nsy-1(gf) (p-value = 0.00).  Together, our findings suggest that there is an 
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inverse relationship between innate immunity and ethanol toxicity, and that nsy-1 activity 
correlates with the concentration of exogenous ethanol.  
It was previously discovered that nsy-1 interacts with downstream gene pmk-1 
(orthologous to mammalian p38 MAP kinase) in response to pathogenic bacterial attack, 
and that pmk-1(lf) mutant worms showed enhanced susceptibility to killing upon 
infection (Troemel et al., 2006). We thus tested whether pmk-1(lf) worms were 
hypersensitive to ethanol toxicity and found significantly impaired crawling behavior in 
comparison to nsy-1(gf) mutants (p-value = 0.00). These findings further support the idea 
that immuno-compromised mutants are more vulnerable to the effects of toxic agents and 
bacterial infection, and for the first time, we show that innate immunity in C. elegans is 
modulated by prolonged ethanol exposure.  
The nsy-1 and pmk-1 loss-of-function mutant animals we tested had lower 
average number of head bends (5.6 and 5.9 head bends/ 20 sec, respectively) than the 
wild-type animals (6.8 head bends/20 sec) in the absence of ethanol treatment (figure 5). 
To account for these genotype-specific crawling differences, we calculated the effect of 
ethanol relative to the untreated crawling rates for each strain. We found nsy-1(lf) and 
pmk-1(lf) mutants showed significantly reduced number of head bends in comparison to 
nsy-1(gf) worms indicating that the crawling deficits are mediated by ethanol and not by 
the specific genotype (p-value = 0.00 for nsy-1(lf) and pmk-1(lf)) (figure 5).   
To further explore alcohol-induced toxicity, we assessed lethality following 
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chronic ethanol exposure. Because earlier results indicated that ethanol treated nsy-1 (lf) 
and pmk-1 (lf) mutant worms had dramatic locomotor impairments, we predicted 
increased lethality rates in these strains. We observed ~ 29% dead pmk-1 (lf) worms in 
comparison to only ~8% dead wild-type animals. Intriguingly, nsy-1 (lf) mutants did not 
display enhanced ethanol-induced lethality as was observed in pmk-1(lf) mutants, with 
only ~ 1% dead worms (figure 6).  
Chronic ethanol exposure results in degeneration of cholinergic neurons 
Analysis and characterization of cholinergic neuronal degeneration in our 
laboratory prompted us to study the effect of chronic alcohol exposure on the health of 
these neurons (VC4 and 5).  Using fluorescent reporters (see methods), we first 
investigated whether alcohol treatment induced cholinergic degeneration in wild type 
strains.  We discovered that this specific subset of cholinergic neurons was dying 
following ethanol treatment (Figure 7). Compared to untreated ‘wild type’ worms, 
ethanol treated worms had significantly higher percentage of VC4 and VC5 degeneration 
(~45%). To our knowledge, this is the first demonstration of cholinergic degeneration 
following prolonged alcohol exposure in C. elegans.  
To test whether increasing nsy-1 activity produced resistance against alcohol-
induced neuoredegeneration, we compared wild-type versus nsy-1(gf) mutant worms and 
found significant resistance in these mutants to damage to cholinergic neuron somas and 
processes (figure 8). This suggests that boosting innate immunity through nsy-1 
ameliorates alcohol-induced toxicity as well as neurodegeneration.    
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DISCUSSION 
We have discovered behavioral effects of prolonged ethanol exposure on C. 
elegans, suggesting this genetically tractable organism is useful for studying conserved 
mechanisms of alcohol-induced effects. Our study complemented previous findings by 
demonstrating that nsy-1(gf) mutants are resistant against the toxic effects of prolonged 
exposure to ethanol in addition to amphetamines and dopamine (Schreiber & McIntire, 
2012).  Moreover, our results provide evidence that genetic modulation of nsy-1 activity 
(by either increasing or decreasing nsy-1 signaling) bidirectionally influences ethanol-
induced toxicity. For instance, we found that nsy-1 gain of function mutants had 
increased crawling rates compared to wild type after chronic treatment to ethanol. 
Conversely, nsy-1(null) mutants showed significantly inhibited locomotion rates 
compared to wild type and nsy-1(gf) worms. This indicates that alcohol exposure may 
trigger activation of the conserved p38 MAP kinase pathway—an innate immune 
signaling cassette that is activated in response to pathogenic attack and osmotic and 
oxidative stress (Krishna and Narang, 2008; Inoue et al., 2005). We propose that 
increased nsy-1 activity increases protein NSY-1/ASK1 synthesis, which in turn may 
promote cell survival and immune-like function yielding protection against toxic agents 
including ethanol.  
We show that alcohol induces degeneration of cholinergic neurons and that 
increasing nsy-1 activity ameliorates this degeneration.  Further experiments will reveal 
whether alcohol exposure triggers degeneration in other classes of neurons, and whether 
this is a patterned degenerative process. Additionally, we will need to investigate ethanol 
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toxicity using lower ethanol concentrations at various time points. By doing so, we will 
determine whether there is a time-dependent effect of ethanol on crawling, 
neurodegeneration and lethality in nsy-1 and pmk-1 mutants. Furthermore, it will be 
important to determine p38/MAP kinase pathway’s activity biochemically and the 
mechanism of ethanol-induced toxicity and neurodegeneration—is neuronal death 
occurring via a necrotic or apoptotic process?  
Deciphering the role of innate immunity in the degenerating central nervous 
system (CNS), identifying the mechanism underlying alcohol-induced neurodegeneration 
and lastly, understanding how alcohol modulates immunity would be vital in providing 
therapeutic approaches for the treatment and prevention of neuronal damage.   
 
CONCLUSION 
Our results suggest that the level of p38 MAP kinase innate immune signaling 
bidirectionally influences alcohol-induced toxicity in C. elegans. To our knowledge, this 
study provides the first example of neurodegeneration following prolonged alcohol in C. 
elegans. We believe this is the first evidence demonstrating that boosting innate immune 
signaling via nsy-1 produces enhanced resistance to alcohol-induced toxicity and 
neurodegeneration. More research is needed for a better understanding of the mechanisms 
of p38 MAP kinase-activity dependent induction of immune response and its role in 
alcohol-induced CNS damage.  We hope that the results presented in this study may 
provide insight into the genetic modulators and signaling pathways associated with 
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alcohol-induced neurodegeneration and toxicity, and that the knowledge learned from 
worms can be tested in species closer in homology to humans, such as rats and mice.  
MATERIALS AND METHODS 
Nematode culture and strains: Strains used were wild-type C. elegans, and mutant strains 
BZ981 nsy-1 (eg691); AU3 nsy-1(ag3); and KU25 pmk- 1(km25). For visualizing VC 
neurons, Ptph-1::GFP (strain LX959)  was used. Strains were grown on nematode growth 
media (NGM) agar plates seeded with OP50 bacteria at 20°C as previously described 
(Brenner et al., 1974).  Animals cultured on plates contaminated with fungi or other 
bacteria were excluded from this study. 
 
Behavioral Tests: For all behavior assays, a suspension of E. coli (50 microliters) was 
placed in the center of plates and allowed to air-dry. Each assay was conducted on worms 
beginning at L4-larval stage onward over several trials. 15 minutes prior to the assay, 
cold 100% ethanol was added to the dried assay treatment plates to a final concentration 
of 400 mM ethanol unless otherwise noted. 
 
Crawling and survival assays: 15 worms were placed on ethanol plates; then plates were 
sealed and stored at room temperature (20°C) and scored for crawling and survival at 72 
hours of ethanol exposure. For locomotion, worms were scored for number of head bends 
in a 20 second window using one-way (single strain concentration effects) or two-way 
(multiple strains comparing both genotype and concentration) ANOVA.  Only worms 
crawling on the bacterial lawn were scored. Significance is indicated for p < 0.05 with 
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Bonferroni correction. For survival, the percentage of dead animals after 72 hours of 
ethanol exposure was compared using Chi-Square Test. 
 
Quantification of Neurodegeneration: Age-synchronized animals were paralyzed on 2% 
agar pads containing 0.7 mM sodium azide.  Neurons that had dimly-lit somas with 
missing/broken projections or absent GFP labeling in the appropriate neuronal location 
were scored as degenerating. All animals were evaluated within 10 minutes of azide 
treatment.  All animals were treated at L4-larval stage onward with the sterilization drug 
5-fluoro-2’-deoxyuridne (FUDR, 0.12mM final) (Sigma).  The percentage of VC4 and 
VC5 neurons that succumbed to alcohol-induced degeneration was compared using one-
way (single strain concentration effects) or two-way (multiple strains comparing both 













Figure 1: TLR signaling in mammals 
 
  























Figure 3: Dose-dependent deficit in crawling after prolonged exposure to ethanol. 
Average number of head bends determined over a 20 second period 
following 72 h exposure to ethanol is shown for wild type (N = 25 trials of 
15 animals per trial). For all figures (except figure 3), data shown are 95% 
mean CI; (*) indicates significance at α = 0.05 (**) α= 0.01 with multiple 








Figure 4: Crawling deficits following prolonged exposure to ethanol in innate immune 
mutants. Boosting innate immune signaling through gain of function 
mutation in nsy-1 resulted in enhanced resistance to ethanol-induced toxicity 
compared to wild type (p-value = 0.00). Loss of function alleles in nsy-1 and 

















Figure 5: normalized to untreated. Increasing activity through nsy-1 gene resulted in 
enhanced resistance to ethanol-induced toxicity compared to wild type. Loss 
of function alleles in nsy-1 and pmk-1 resulted in hypersensitivity to ethanol 




















Figure 6: Lethal effect of prolonged exposure to ethanol. pmk-1(lf) mutants exhibited 
higher lethality (29.3%) to ethanol in comparison to wild type animals 
(8.3%). Lethality is less than 1% for untreated strains. Statistical analysis 





















Figure 7: Chronic ethanol exposure results in degeneration of cholinergic neurons in wild 
type worms. On 400mM, wild type exhibited 47% degeneration.  Untreated 

























Figure 8: Boosting innate immune signaling protects against alcohol-induced cholinergic 
degeneration. nsy-1(gf) mutants show lower % degeneration (35%) 
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